You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0329 A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat when Treating Hyperuricemia Associated with Gout

Citation Tools

Article menu
Download PDFPDF
Poster Presentations
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
FRI0329 A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat when Treating Hyperuricemia Associated with Gout

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Steinberg A, Vince B, Choi Y, et al
FRI0329 A Study to Evaluate the Pharmacodynamics, Pharmacokinetics and Safety of Arhalofenate in Combination with Febuxostat when Treating Hyperuricemia Associated with Gout
Annals of the Rheumatic Diseases 2015;74:543-544.